2-Year U.S. Treasury Note Continuous Contract $104.375 0.004 0.00% 5-Year U.S. Treasury Note Continuous Contract $109.195 0.031 0.03% 10-Year U.S. Treasury Note Continuous Contract $112.250 0.047 0.04 ...

The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...